MARKET RADAR
SENSEX     NIFTY      
Ranbaxy Laboratories | Auditor's Report > Pharmaceuticals > Auditor's Report from Ranbaxy Laboratories - BSE: 500359, NSE: RANBAXY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > AUDITORS REPORT - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
  
LIVE
BSE
Feb 10, 15:59
443.30
-8.25 (-1.83%)
VOLUME 80,326
LIVE
NSE
Feb 10, 15:58
442.40
-9.45 (-2.09%)
VOLUME 510,967
Explore Ranbaxy Labs connections « Dec 09
Auditor's Report (Ranbaxy Laboratories) Year End : Dec '10

 
 
 
 
 
 Ranbaxy (AR2010) final Grid Page_BW.CDR
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 

a)      We have audited the attached Balance sheet of Ranbaxy laboratories limited (‘the company’) as at 31 December 2010 and also the Profit and loss account and the cash Flow statement (collectively referred to as ‘financial statements’) of the company for the year ended on that date, annexed thereto. These financial statements are the responsibility of the company’s management. Our responsibility is to express an opinion on these financial statements based on our audit.

b)     We conducted our audit in accordance with auditing standards generally accepted in India. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. an audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. an audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statements presentation. We believe that our audit provides a reasonable basis for our opinion.

c)      As required by the companies (auditor’s report) Order, 2003 (‘the Order’) issued by the central Government of India in terms of sub-section (4a) of section 227 of the companies act, 1956, (“the act”), we enclose in the Annexure, a statement on the matters specified in paragraphs 4 and 5 of the said Order.

d)     Further to our comments in the Annexure referred to above, we report that:

(i) we have obtained all the information and explanations, which to the best of our knowledge and belief were necessary for the purposes of our audit; (ii) in our opinion, proper books of account as required by law have been kept by the company so far as appears from our examination of those books; (iii) the Balance sheet, Profit and loss account and cash Flow statement dealt with by this report are in agreement with the books of account; (iv) in our opinion, the Balance sheet, Profit and loss account and cash Flow statement dealt with by this report comply with the accounting standards referred to in sub-section (3c) of section 211 of the act, to the extent applicable; (v) on the basis of written representations received from the directors of the company as at 31 December 2010, and taken on record by the Board of directors, we report that none of the directors is disqualified as at 31 December 2010 from being appointed as a Director in terms of clause (g) of sub-section (1) of section 274 of the act;

e)      Without qualifying our opinion, we draw attention to note 2 of schedule 23 of the financial statements, wherein it has been stated that the company continues to cooperate, for an effective resolution, with:

•       The Food and Drug administration of the united states of America for import alert and warning letters issued primarily relating to Good Manufacturing Practice for some of the products manufactured at certain manufacturing facilities of the company in India and application Integrity Policy against one of its manufacturing facility in India; and

•       The Department of Justice of the united states of America regarding certain charges relating to possible issues with data submitted by the company in support of product filings.

Due to the inherent uncertainty of the outcome of the above mentioned matters, financial impact, if any, of the outcome cannot be reliably ascertained at this stage, and accordingly, no adjustment has been made to these financial statements.

f)       Without qualifying our report, we draw attention to note 14 of schedule 23 of the financial statements, wherein it is stated that the appointment and remuneration of Mr. Arun Sawhney as the Managing Director of the company with effect from 20 august 2010 has been approved by the Board of Directors, but the requisite regulatory approval from shareholders is yet to be obtained. In accordance with the remuneration determined by the Board of Directors, Rs. 32.91 million (including commission) has been accounted for as an expense in the Profit and loss account for the year ended 31 December 2010.

g)      In our opinion and to the best of our information and according to the explanations given to us, the said financial statements give the information required by the act, in the manner so required and gives a true and fair view in conformity with the accounting principles generally accepted in India:

i) In the case of the Balance sheet, of the state of the affairs of the company as at 31 December 2010;

ii) In the case of the Profit and loss account, of the profit of the company for the year ended on that date; and

iii) In the case of the cash Flow statement, of the cash flows of the company for the year ended on that date.

Annexure to the Auditors’ Report (referred to in our report of even date)

(i) (a) The company has maintained proper records showing full particulars, including quantitative details and situation of its fixed assets.

(b)     The company has a regular programme of physical verification of its fixed assets through which all fixed assets are verified, in a phased manner, over a period of three years. In our opinion, this periodicity of physical verification is reasonable having regard to the size of the company and the nature of its assets. no material discrepancies were noticed on such verification.

(c)     Fixed assets disposed off during the year were not substantial, and therefore, do not affect the going concern assumption.

(ii) (a) The inventory, except goods-in-transit, has been physically verified by the management during the year. In our opinion, the frequency of such verification is reasonable.

(b)     In our opinion, the procedures of physical verification of inventory followed by the management are reasonable and adequate in relation to the size of the company and the nature of its business.

(c)     The company is maintaining proper records of inventory. The discrepancies noticed on verification between the physical stocks and the book records were not material.

(iii) The company has neither granted nor taken any loans, secured or unsecured, to or from companies, firms or other parties covered in the register maintained under section 301 of the companies act, 1956.

(iv) In our opinion and according to the information and explanations given to us, and having regard to the explanation that sale of certain items of goods are for the specialised requirements of the buyers and suitable alternative sources are not available to obtain comparable quotations, there is an adequate internal control system commensurate with the size of the company and the nature of its business with regard to purchase of inventories and fixed assets and for sale of goods and services. Further, on the basis of our examination and according to information and explanations given to us, there has been no continuing failure to correct the weaknesses in the aforesaid internal control system, and adequate action is being taken by the management to rectify any weaknesses, as identified.

(v) In our opinion and according to the information and explanations given to us, there are no contracts and arrangements, the particulars of which need to be entered into the register maintained under section 301 of the companies act, 1956.

(vi) The company has not accepted any deposits from the public.

(vii) In our opinion, the company has an internal audit system commensurate with the size and nature of its business.

(viii) We have broadly reviewed the books of account maintained by the company pursuant to the rules prescribed by the central Government for maintenance of cost records under section 209(1)(d) of the companies act, 1956, in respect of its products and are of the opinion that prima facie, the prescribed accounts and records have been made and maintained. However, we have not carried out a detailed examination of the records with a view to determine whether these are accurate or complete.

(ix) (a) according to the information and explanations given to us, and on the basis of our examination of the records of the company, amounts deducted / accrued in the books of account in respect of undisputed statutory dues including Provident fund, Investor education and protection fund, employees’ state insurance, Income tax, sales tax, Wealth tax, service tax, customs duty, excise duty and other material statutory dues have generally been regularly deposited during the year by the company with the appropriate authorities.

There were no dues on account of cess under section 441a of the companies act, 1956, since the date, from which the aforesaid section comes into force, has not yet been notified by the central Government.

According to the information and explanations given to us, no undisputed amounts payable in respect of Provident fund, Investor education and protection fund, employees’ state insurance, Income tax, sales tax, Wealth tax, service tax, customs duty, excise duty and other material statutory dues were in arrears as at 31 December 2010 for a period of more than six months from the date those became payable.

(b) According to the information and explanations given to us, there are no dues of Income tax, Wealth tax, service tax and customs duty which have not been deposited with the appropriate authorities on account of any dispute. according to the information and explanations given to us, the following dues of sales tax and excise duty have not been deposited by the company on account of disputes:

Name of the Statute

Nature of the dues

Amount (Rs. in million)

Period to which the amount relates

Forum where disputes are pending

central excise act, 1944

central excise (CENVAaT, Interest and Penalty)

39.90

2001-2006

supreme Court / High Court/ CESTAT / commissioner

Punjab General sales Tax act, 1948.

Purchase Tax (Interest and Penalty)

2.25

1989-90 and 1990-91

sales Tax Tribunal

U.P. sales Tax act, 1948.

sales Tax

13.73

2007-09

High court, Lucknow / Sales Tax Tribunal / additional commissioner

(x) The company does not have any accumulated losses at the end of the financial year and has not incurred cash losses in the financial year and in the immediately preceding financial year.

(xi) In our opinion and according to the information and explanations given to us, the company has not defaulted in repayment of dues to its bankers or debenture holders. There were no dues to financial institutions.

(xii) The company has not granted any loans and advances on the basis of security by way of pledge of shares, debentures and other securities.

(xiii) In our opinion and according to the information and explanations given to us, the company is not a chit fund or a nidhi / mutual benefit fund / society.

(xiv) According to the information and explanations given to us, the company is not dealing or trading in shares, securities, debentures and other investments.

(xv) In our opinion and according to the information and explanations given to us, the terms and conditions on which the company has issued letters of comfort, in respect of loans taken by its subsidiary companies from banks, are not prejudicial to the interest of the company.

(xvi) In our opinion and according to the information and explanations given to us, the term loans taken by the company during the year are lying unutilised as at the year end.

(xvii) According to the information and explanations given to us, and on an overall examination of the balance sheet of the company, we are of the opinion that the funds raised on short-term basis have not been used for long-term investment.

(xviii) The company has not made any preferential allotment of shares during the year to companies/ firms/ parties covered in the register maintained under section 301 of the companies act, 1956.

(xix) The company has issued non-convertible debentures during the year which were redeemed before the year end. according to the information and explanations given to us, security was not created in respect of these debentures as these were redeemed before expiry of the time limit for creation of security as stipulated in the letters of allotment.

(xx) The company has not raised any money by public issues during the year.

(xxi) according to the information and explanations given to us, no material fraud on or by the company has been noticed or reported during the course of our audit. However, as informed to us, a case of misappropriation of funds through falsification of documents resulting in a minor fraud to the extent of approximately Rs. 3 million has been noticed during the year. as further informed to us, the company has taken adequate follow up action, including strengthening of systems.

 

For B S R & Co.

Chartered Accountants Membership no. 101248W

Place : Gurgaon

Dated : 22 February 2011

Vikram Aggarwal

Partner

Membership no. 089826

 

Source : Dion Global Solutions Limited
Quick Links for ranbaxylaboratories
Follow moneycontrol.com

Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.